AztraZeneca fights to regain cancer market prominence
June 03, 2014 at 17:11 PM EDT
CHICAGO, June 3 (Reuters) - AstraZeneca Plc, in the headlines for spurning buyout offers from Pfizer Inc, aims to regain prominence in oncology with compelling trial results and a splashy exhibit booth at the world's largest meeting of cancer doctors.